Lukas P - Search Results

1

Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.

Egle A, Villunger A, Marschitz I, Kos M, Hittmair A, Lukas P, Grünewald K, Greil R. Egle A, et al. Among authors: lukas p. Br J Haematol. 1997 May;97(2):418-28. doi: 10.1046/j.1365-2141.1997.382680.x. Br J Haematol. 1997. PMID: 9163609 Free article.

2

Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.

Eisterer W, De Vries A, Öfner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J; Austrian Breast and Colorectal Cancer Study Group (ABCSG). Eisterer W, et al. Among authors: lukas p. Anticancer Res. 2014 Nov;34(11):6767-73. Anticancer Res. 2014. PMID: 25368289 Clinical Trial.

3

Irreversible pan-ErbB tyrosine kinase inhibitor CI-1033 induces caspase-independent apoptosis in colorectal cancer DiFi cell line.

Skvortsov S, Skvortsova I, Sarg B, Loeffler-Ragg J, Lindner H, Lukas P, Tabernero J, Zwierzina H. Skvortsov S, et al. Among authors: lukas p. Apoptosis. 2005 Oct;10(5):1175-86. doi: 10.1007/s10495-005-1322-4. Apoptosis. 2005. PMID: 16151650

4

Antitumor activity of CTFB, a novel anticancer agent, is associated with the down-regulation of nuclear factor-kappaB expression and proteasome activation in head and neck squamous carcinoma cell lines.

Skvortsov S, Skvortsova I, Stasyk T, Schiefermeier N, Neher A, Gunkel AR, Bonn GK, Huber LA, Lukas P, Pleiman CM, Zwierzina H. Skvortsov S, et al. Among authors: lukas p. Mol Cancer Ther. 2007 Jun;6(6):1898-908. doi: 10.1158/1535-7163.MCT-06-0708. Mol Cancer Ther. 2007. PMID: 17575118

5

Rituximab enhances radiation-triggered apoptosis in non-Hodgkin's lymphoma cells via caspase-dependent and - independent mechanisms.

Skvortsova I, Skvortsov S, Popper BA, Haidenberger A, Saurer M, Gunkel AR, Zwierzina H, Lukas P. Skvortsova I, et al. Among authors: lukas p. J Radiat Res. 2006 Jun;47(2):183-96. doi: 10.1269/jrr.47.183. J Radiat Res. 2006. PMID: 16819145 Free article.

6

Different proteome pattern of epidermal growth factor receptor-positive colorectal cancer cell lines that are responsive and nonresponsive to C225 antibody treatment.

Skvortsov S, Sarg B, Loeffler-Ragg J, Skvortsova I, Lindner H, Werner Ott H, Lukas P, Illmensee K, Zwierzina H. Skvortsov S, et al. Among authors: lukas p. Mol Cancer Ther. 2004 Dec;3(12):1551-8. Mol Cancer Ther. 2004. PMID: 15634648

7

Pretreatment with rituximab enhances radiosensitivity of non-Hodgkin's lymphoma cells.

Skvortsova I, Popper BA, Skvortsov S, Saurer M, Auer T, Moser R, Kamleitner H, Zwierzina H, Lukas P. Skvortsova I, et al. Among authors: lukas p. J Radiat Res. 2005 Jun;46(2):241-8. doi: 10.1269/jrr.46.241. J Radiat Res. 2005. PMID: 15988143 Free article.

8

How successful are oncologists in identifying patient distress, perceived social support, and need for psychosocial counselling?

Söllner W, DeVries A, Steixner E, Lukas P, Sprinzl G, Rumpold G, Maislinger S. Söllner W, et al. Among authors: lukas p. Br J Cancer. 2001 Jan;84(2):179-85. doi: 10.1054/bjoc.2000.1545. Br J Cancer. 2001. PMID: 11161373 Free PMC article.

9

Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study.

Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M, Kapp KS, Fastner G, Keil F, Eisterer W, Jäger R, Offner F, Gnant M, Thaler J; TAKO 05/ABCSG R-02 Trial Investigators. Ofner D, et al. Strahlenther Onkol. 2011 Feb;187(2):100-7. doi: 10.1007/s00066-010-2182-6. Epub 2011 Jan 21. Strahlenther Onkol. 2011. PMID: 21267531 Clinical Trial.

10

Rac1 as a potential therapeutic target for chemo-radioresistant head and neck squamous cell carcinomas (HNSCC).

Skvortsov S, Dudás J, Eichberger P, Witsch-Baumgartner M, Loeffler-Ragg J, Pritz C, Schartinger VH, Maier H, Hall J, Debbage P, Riechelmann H, Lukas P, Skvortsova I; EORTC PathoBiology Group. Skvortsov S, et al. Among authors: lukas p. Br J Cancer. 2014 May 27;110(11):2677-87. doi: 10.1038/bjc.2014.221. Epub 2014 May 1. Br J Cancer. 2014. PMID: 24786604 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

206 results

Search Page

Filters